Skip to content

Efficacy of the Valsalva Maneuver on Needle Projection Pain and Hemodynamic Responses During Spinal Puncture, a randomized clinical trial

Efficacy of the Valsalva Maneuver on Needle Projection Pain and Hemodynamic Responses During Spinal Puncture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201011285264N2
Enrollment
30
Registered
2011-01-31
Start date
2010-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal needle projection pain. Procedures for purposes other than remedying health state

Interventions

Intervention 1: Group II (B): Ball
pressed a rubber ball for diversion of patients attention (attention-diverting method). Intervention 2: Group III (V): Valsalva
blew into sphygmomanometer tubing and hold the mercury column up to 30 mm Hg for a period of at least 20s. Intervention 3: Group I (C): Control (no intervention).
Group II (B): Ball
pressed a rubber ball for diversion of patients attention (attention-diverting method)
Group III (V): Valsalva
blew into sphygmomanometer tubing and hold the mercury column up to 30 mm Hg for a period of at least 20s.
Group I (C): Control (no intervention)

Sponsors

Tehran university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
19 Years to 75 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients, either sex with ASA physical status I and II, scheduled for elective surgeries under spinal anesthesia. Exclusion criteria: 1) Patients having problems in communication 2) any contraindications to spinal anesthesia 3) Patients who could not hold the mercury column up to 30 mm Hg for a period of at least 20s 4)patients whose spinal puncture could not be performed in the first attempt.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: degree of pain after valsalva maneuver. Method of measurement: numeric rating scale.

Secondary

MeasureTime frame
Hemodynamic responses. Timepoint: 5 minute before, during and 1 and 3 minute after intervention. Method of measurement: heart rate and blood pressure.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSussan Soltani Mohammadi

Tehran University of Medical Sciences

soltanmo@sina.tums.ac.ir , soltanmo@gmail.com+98 21 2229 5296

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026